As we observe a correlation between SPHKAP variant effects in T2D and high BMI (as a proxy for obesity), we propose here that SPHKAP might play a pleiotropic role in both disorders by the engagement of common signalling pathways in different tissues. Here, SPHKAP is linked to type 2 diabetes mellitus.